Plus Therapeutics Q2 Sales $1.28M Miss $1.68M Estimate
Portfolio Pulse from Benzinga Newsdesk
Plus Therapeutics (NASDAQ:PSTV) reported Q2 sales of $1.28 million, missing the analyst consensus estimate of $1.68 million by 23.64%. This represents a 31.01% decrease from the same period last year.
August 14, 2024 | 8:15 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Plus Therapeutics reported Q2 sales of $1.28 million, missing the analyst consensus estimate of $1.68 million by 23.64%. This is a 31.01% decrease from the same period last year.
The significant miss on sales estimates and the year-over-year decline in sales are likely to negatively impact investor sentiment and the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100